Learn how the Mediterranean diet can help manage and even reverse MASH by supporting liver health, reducing inflammation, and ...
Terns Pharmaceuticals, Inc.’s TERN share price has surged by 14.97%, which has investors questioning if this is right time to ...
Older studies that concluded that too much red meat is harmful to your health have many limitations, based on newer findings.
Histoindex Pte Ltd. launched its laboratory-developed test for metabolic dysfunction-associated steatohepatitis (MASH), ...
PathAI, a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has granted full qualification for ...
Galmed (GLMD) announced the grant of a new patent related to its lead compound, Aramchol. The patent covers the use of a combination therapy of ...
The FDA has granted approval to an act of compassionate use treatment with the anti-cancer drug Namodenoson for a patient ...
Non-alcoholic fatty liver disease (NAFLD) represents the most common liver disease worldwide affecting approximatively 20–30% ...
Findings in multinational study show MRI, using LiverMultiScan, is a cost-effective tool to help doctors diagnose more people ...
We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...
HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the launch of their first Laboratory Developed Test (LDT) FibroSIGHTtm ? now ...
Medically reviewed by Jay N. Yepuri, MD Metabolic dysfunction-associated steatohepatitis (MASH) is an advanced form of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results